November 17, 2016 - By Dolores Ford · 0 Comments
Retractable Technologies Inc (NYSEMKT:RVP) institutional sentiment increased to 1.5 in Q2 2016. Its up 0.50, from 1 in 2016Q1. The ratio is better, as 9 hedge funds opened new or increased positions, while 6 sold and decreased their stock positions in Retractable Technologies Inc. The hedge funds in our partner’s database now own: 1.50 million shares, down from 1.68 million shares in 2016Q1. Also, the number of hedge funds holding Retractable Technologies Inc in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 3 Reduced: 3 Increased: 8 New Position: 1.
Retractable Technologies, Inc. designs, develops and makes safety medical products for the healthcare industry. The company has a market cap of $73.82 million. The Firm markets VanishPoint and PatientSafe products. It currently has negative earnings. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse.
About 3,877 shares traded hands. Retractable Technologies, Inc. (NYSEMKT:RVP) has risen 14.29% since April 15, 2016 and is uptrending. It has outperformed by 9.66% the S&P500.
According to Zacks Investment Research, “Retractable Technologies, Inc. designs, develops, manufactures, and markets innovative patented safety needle devices for the healthcare industry.”
Wealthtrust Axiom Llc holds 0.38% of its portfolio in Retractable Technologies, Inc. for 394,869 shares. Cannell Capital Llc owns 166,762 shares or 0.17% of their US portfolio. Moreover, Ancora Advisors Llc has 0.03% invested in the company for 93,717 shares. The Minnesota-based Whitebox Advisors Llc has invested 0.01% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 71,439 shares.#img1#
Retractable Technologies, Inc., incorporated on May 9, 1994, designs, develops and makes safety medical products for the healthcare industry. The Firm markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products consist of tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1 mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe. The Firm also sells the VanishPoint intravenous (IV) catheter, the VanishPoint blood collection tube holder and the VanishPoint blood collection set. The PatientSafe syringe reduces the risk of bloodstream infections resulting from catheter hub contamination. The Company’s PatientSafe products consist of 3mL, 5mL, 10mL, 20mL, 30mL and 60mL syringes, and the PatientSafe Luer cap.
More notable recent Retractable Technologies, Inc. (NYSEMKT:RVP) news were published by: Businesswire.com which released: “Retractable Technologies, Inc. Reports Results as of September 30, 2016” on November 14, 2016, also Marketwatch.com with their article: “Retractable Technologies Inc.” published on July 21, 2009, Businesswire.com published: “Retractable Technologies, Inc. Reports Results as of June 30, 2016” on August 16, 2016. More interesting news about Retractable Technologies, Inc. (NYSEMKT:RVP) were released by: Businesswire.com and their article: “Retractable Technologies, Inc. Reports Results for the First Quarter of 2016” published on May 17, 2016 as well as Businesswire.com‘s news article titled: “Oral Argument Calendared for Retractable Technologies, Inc.” with publication date: January 28, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Dolores Ford